Clinical Trial Update: A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Velcade (bortezomib) with chemoradiation in patients with brain/CNS neoplasms and head-and-neck/cervical cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Central Nervous System Neoplasms
• Cervical Cancer
• Head and Neck Cancer

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Brain Cancer, Head and Neck Cancer | Phase 1 | Status: COMPLETED